{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:09:40Z","timestamp":1770455380367,"version":"3.49.0"},"reference-count":138,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1586\/14737175.2014.953931","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T08:14:00Z","timestamp":1409127240000},"page":"1139-1152","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":30,"title":["Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions"],"prefix":"10.1586","volume":"14","author":[{"given":"Katherine E","family":"Schwetye","sequence":"first","affiliation":[{"name":"Department of Pathology, Division of Neuropathology, Washington University School of Medicine,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H","family":"Gutmann","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2011.04.009"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2014.857400"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.278"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0b013e3181ee3833"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520290115023"},{"issue":"4","key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0888-7543(91)90017-9","article-title":"cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product","volume":"11","author":"Marchuk DA","year":"1991","unstructured":"Marchuk DA, Saulino AM, Tavakkol R, et al. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 1991;11(4):931-40","journal-title":"Genomics"},{"issue":"21","key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1073\/pnas.88.21.9658","article-title":"Identification of the neurofibromatosis type 1 gene product","volume":"88","author":"Gutmann DH","year":"1991","unstructured":"Gutmann DH, Wood DL, Collins FS. Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 1991;88(21):9658-62","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/(SICI)1098-1004(1997)9:6<548::AID-HUMU8>3.0.CO;2-Y","article-title":"NF1 mutation analysis using a combined heteroduplex\/SSCP approach","volume":"9","author":"Abernathy CR","year":"1997","unstructured":"Abernathy CR, Rasmussen SA, Stalker HJ, et al. NF1 mutation analysis using a combined heteroduplex\/SSCP approach. Hum Mutat 1997;9(6):548-54","journal-title":"Hum Mutat"},{"issue":"5","key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1","article-title":"Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1?","volume":"9","author":"Cnossen MH","year":"1997","unstructured":"Cnossen MH, van der Est MN, Breuning MH, et al. Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1? Hum Mutat 1997;9(5):458-64","journal-title":"Hum Mutat"},{"issue":"3","key":"e_1_3_3_11_1","first-page":"424","article-title":"Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients","volume":"54","author":"Kayes LM","year":"1994","unstructured":"Kayes LM, Burke W, Riccardi VM, et al. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet 1994;54(3):424-36","journal-title":"Am J Hum Genet"},{"issue":"2","key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P","article-title":"Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata","volume":"73","author":"Leppig KA","year":"1997","unstructured":"Leppig KA, Kaplan P, Viskochil D, et al. Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata. Am J Med Genet 1997;73(2):197-204","journal-title":"Am J Med Genet"},{"issue":"1","key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N","article-title":"Do NF1 gene deletions result in a characteristic phenotype?","volume":"73","author":"Tonsgard JH","year":"1997","unstructured":"Tonsgard JH, Yelavarthi KK, Cushner S, et al. Do NF1 gene deletions result in a characteristic phenotype? Am J Med Genet 1997;73(1):80-6","journal-title":"Am J Med Genet"},{"issue":"8","key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/088307380201700804","article-title":"Genetics of neurofibromatosis 1 and the NF1 gene","volume":"17","author":"Viskochil D","year":"2002","unstructured":"Viskochil D. Genetics of neurofibromatosis 1 and the NF1 gene. J Child Neurol 2002;17(8):562-70; discussion 571-562, 646-551","journal-title":"J Child Neurol"},{"issue":"4","key":"e_1_3_3_15_1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ajmg.1320590427","article-title":"Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations","volume":"59","author":"Wu BL","year":"1995","unstructured":"Wu BL, Austin MA, Schneider GH, et al. Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations. Am J Med Genet 1995;59(4):528-35","journal-title":"Am J Med Genet"},{"issue":"1","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1096-8628(19970303)69:1<98::AID-AJMG19>3.0.CO;2-J","article-title":"Deletion of the entire NF1 gene causing distinct manifestations in a family","volume":"69","author":"Wu BL","year":"1997","unstructured":"Wu BL, Schneider GH, Korf BR. Deletion of the entire NF1 gene causing distinct manifestations in a family. Am J Med Genet 1997;69(1):98-101","journal-title":"Am J Med Genet"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-012-0332-y"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21271"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1086\/510781"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.6.e82"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2010.081760"},{"issue":"2","key":"e_1_3_3_22_1","first-page":"305","article-title":"An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes","volume":"53","author":"Easton DF","year":"1993","unstructured":"Easton DF, Ponder MA, Huson SM, Ponder BA. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 1993;53(2):305-13","journal-title":"Am J Hum Genet"},{"issue":"2","key":"e_1_3_3_23_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ajmg.a.20354","article-title":"Analysis of neurofibromatosis 1 (NF1) lesions by body segment","volume":"125","author":"Palmer C","year":"2004","unstructured":"Palmer C, Szudek J, Joe H, et al. Analysis of neurofibromatosis 1 (NF1) lesions by body segment. Am J Med Genet A 2004;125A(2):157-61","journal-title":"Am J Med Genet A"},{"issue":"4","key":"e_1_3_3_24_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/1098-2272(200012)19:4<429::AID-GEPI13>3.0.CO;2-N","article-title":"Associations of clinical features in neurofibromatosis 1 (NF1)","volume":"19","author":"Szudek J","year":"2000","unstructured":"Szudek J, Birch P, Riccardi VM, et al. Associations of clinical features in neurofibromatosis 1 (NF1). Genet Epidemiol 2000;19(4):429-39","journal-title":"Genet Epidemiol"},{"issue":"5","key":"e_1_3_3_25_1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1212\/WNL.0000000000000652","article-title":"Eliminating barriers to personalized medicine: Learning from neurofibromatosis type 1","volume":"83","author":"Gutmann DH","year":"2014","unstructured":"Gutmann DH. Eliminating barriers to personalized medicine: Learning from neurofibromatosis type 1. Neurology 2014;83(5):463-71","journal-title":"Neurology"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2012.04399.x"},{"key":"e_1_3_3_27_1","volume-title":"Neurofibromatosis type 1 in childhood","author":"North K","year":"1997","unstructured":"North K, Gutmann DH. International Child Neurology Association. Neurofibromatosis type 1 in childhood. Mac Keith Press, for the International Child Neurology Association; London, England: 1997"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(96)00022-6"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83163-4"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000179303.72345.ce"},{"key":"e_1_3_3_31_1","first-page":"19","article-title":"Language and reading deficits associated with neurofibromatosis type 1: evidence for a not-so-nonverbal learning disability","volume":"11","author":"Mazzocco M TJ","year":"1995","unstructured":"Mazzocco M TJ, Denckla M, Hofman K, et al. Language and reading deficits associated with neurofibromatosis type 1: evidence for a not-so-nonverbal learning disability. Dev Neuropsychol 1995;11:19","journal-title":"Dev Neuropsychol"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073808316366"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004703-198606000-00009"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.26.11.712"},{"issue":"5","key":"e_1_3_3_35_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004703-198810000-00003","article-title":"Neurofibromatosis and psychological processes","volume":"9","author":"Varnhagen CK","year":"1988","unstructured":"Varnhagen CK, Lewin S, Das JP, et al. Neurofibromatosis and psychological processes. J Dev Behav Pediatr 1988;9(5):257-65","journal-title":"J Dev Behav Pediatr"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1540-5826.2004.00099.x","article-title":"Cognitive profile of neurofibromatosis type 1: rethinking nonverbal learning disabilities","volume":"19","author":"Cutting LE","year":"2004","unstructured":"Cutting LE, Clements AM, Lightman AD, et al. Cognitive profile of neurofibromatosis type 1: rethinking nonverbal learning disabilities. Learn Disabil Res Pract 2004;19:10","journal-title":"Learn Disabil Res Pract"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2009.12.008"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2779(2000)6:2<117::AID-MRDD5>3.0.CO;2-X"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2006.01.006"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073809350723"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1017\/S135561771000086X"},{"issue":"1","key":"e_1_3_3_43_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2788.2005.00660.x","article-title":"Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children","volume":"49","author":"Descheemaeker MJ","year":"2005","unstructured":"Descheemaeker MJ, Ghesquiere P, Symons H, et al. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children. J Intellect Disabil Res 2005;49(Pt 1):33-46","journal-title":"J Intellect Disabil Res"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1004829107"},{"issue":"5","key":"e_1_3_3_45_1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1469-8749.1995.tb12026.x","article-title":"Cognitive function and academic performance in children with neurofibromatosis type 1","volume":"37","author":"North K","year":"1995","unstructured":"North K, Joy P, Yuille D, et al. Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 1995;37(5):427-36","journal-title":"Dev Med Child Neurol"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/09297049.2010.542746"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812439435"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2007.09.013"},{"issue":"5","key":"e_1_3_3_49_1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10519-005-9040-9","article-title":"Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children","volume":"36","author":"Coude FX","year":"2006","unstructured":"Coude FX, Mignot C, Lyonnet S, Munnich A. Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children. Behav Genet 2006;36(5):660-4","journal-title":"Behav Genet"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/09297041003761985"},{"issue":"7","key":"e_1_3_3_51_1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/archpedi.1989.02150190083027","article-title":"Neurofibromatosis type 1 (Recklinghausen\u2019s disease). Neurologic and cognitive assessment with sibling controls","volume":"143","author":"Eldridge R","year":"1989","unstructured":"Eldridge R, Denckla MB, Bien E, et al. Neurofibromatosis type 1 (Recklinghausen\u2019s disease). Neurologic and cognitive assessment with sibling controls. Am J Dis Child 1989;143(7):833-7","journal-title":"Am J Dis Child"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1076\/chin.6.3.185.3155"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2002.tb00780.x"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073809358454"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/09297040701595505"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2011.06.014"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcomdis.2013.12.002"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/01688639608408302"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/87565641.2010.508670"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq382"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature711"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/86898"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.09.060"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0397-281"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1207\/S15326942DN1701_02"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004703-199608000-00004"},{"issue":"6","key":"e_1_3_3_67_1","first-page":"565","article-title":"Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings","volume":"51","author":"Erdogan-Bakar E","year":"2009","unstructured":"Erdogan-Bakar E, Cinbis M, Ozyurek H, et al. Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings. Turk J Pediatr 2009;51(6):565-71","journal-title":"Turk J Pediatr"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206002131"},{"issue":"4","key":"e_1_3_3_69_1","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1212\/WNL.54.4.914","article-title":"Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status","volume":"54","author":"Moore BD","year":"2000","unstructured":"Moore BD 3rd, Slopis JM, Jackson EF, et al. Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology 2000;54(4):914-20","journal-title":"Neurology"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.20048"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038785"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1186\/1866-1955-6-4"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162204000921"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70296-9"},{"issue":"19","key":"e_1_3_3_75_1","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/ajmg.a.31923","article-title":"Social, emotional, and behavioral functioning of children with NF1","volume":"143","author":"Noll RB","year":"2007","unstructured":"Noll RB, Reiter-Purtill J, Moore BD, et al. Social, emotional, and behavioral functioning of children with NF1. Am J Med Genet A 2007;143(19):2261-73","journal-title":"Am J Med Genet A"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10519-010-9430-5"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162205000460"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1868"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12038"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01487072"},{"issue":"1","key":"e_1_3_3_81_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02408551","article-title":"Childhood psychosis and neurofibromatosis--more than a coincidence?","volume":"14","author":"Gillberg C","year":"1984","unstructured":"Gillberg C, Forsell C. Childhood psychosis and neurofibromatosis--more than a coincidence? J Autism Dev Disord 1984;14(1):1-8","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"e_1_3_3_82_1","first-page":"15","article-title":"Neurofibromatosis in infantile autism and other types of childhood psychoses","volume":"55","author":"Mouridsen SE","year":"1992","unstructured":"Mouridsen SE, Andersen LB, Sorensen SA, et al. Neurofibromatosis in infantile autism and other types of childhood psychoses. Acta Paedopsychiatr 1992;55(1):15-18","journal-title":"Acta Paedopsychiatr"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674378903400613"},{"issue":"6","key":"e_1_3_3_84_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1023\/A:1026012414193","article-title":"Brief report: the association of neurofibromatosis type 1 and autism","volume":"28","author":"Williams PG","year":"1998","unstructured":"Williams PG, Hersh JH. Brief report: the association of neurofibromatosis type 1 and autism. J Autism Dev Disord 1998;28(6):567-71","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"e_1_3_3_85_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jmedgenet-2013-101951","article-title":"Autism traits in the RASopathies","volume":"51","author":"Adviento B","year":"2014","unstructured":"Adviento B, Corbin IL, Widjaja F, et al. Autism traits in the RASopathies. J Med Genet 2014;51(1):10-20","journal-title":"J Med Genet"},{"issue":"7","key":"e_1_3_3_86_1","first-page":"s","article-title":"Autism genetics: searching for specificity and convergence","volume":"13","author":"Berg JM","year":"2012","unstructured":"Berg JM, Geschwind DH. Autism genetics: searching for specificity and convergence. Genome Biol 2012;13(7):s","journal-title":"Genome Biol"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.10.001"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1177\/08830738030180110701"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2003.07.008"},{"issue":"1","key":"e_1_3_3_90_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcn.2011.08.008","article-title":"Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP\/PKA\/ROCK-dependent manner","volume":"49","author":"Brown JA","year":"2012","unstructured":"Brown JA, Diggs-Andrews KA, Gianino SM, Gutmann DH. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP\/PKA\/ROCK-dependent manner. Mol Cell Neurosci 2012;49(1):13-22","journal-title":"Mol Cell Neurosci"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3994-09.2010"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-26-08949.2003"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5313.795"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/35002593"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2007.07.008"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5313.791"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn792"},{"issue":"7","key":"e_1_3_3_98_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/hmg\/ddl023","article-title":"Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras","volume":"15","author":"Hannan F","year":"2006","unstructured":"Hannan F, Ho I, Tong JJ, et al. Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras. Hum Mol Genet 2006;15(7):1087-98","journal-title":"Hum Mol Genet"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn194"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.13.1.487-495.1993"},{"issue":"10","key":"e_1_3_3_101_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/dna.1992.11.727","article-title":"Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and absence of expression in a neuroblastoma line","volume":"11","author":"Bernards A","year":"1992","unstructured":"Bernards A, Haase VH, Murthy AE, et al. Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and absence of expression in a neuroblastoma line. DNA Cell Biol 1992;11(10):727-34","journal-title":"DNA Cell Biol"},{"issue":"5","key":"e_1_3_3_102_1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/hmg\/4.5.915","article-title":"Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5\u2019 part of the gene","volume":"4","author":"Danglot G","year":"1995","unstructured":"Danglot G, Regnier V, Fauvet D, et al. Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5\u2019 part of the gene. Hum Mol Genet 1995;4(5):915-20","journal-title":"Hum Mol Genet"},{"issue":"8","key":"e_1_3_3_103_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0753-3322(94)90053-1","article-title":"Tissue-specific alternative splicing of neurofibromatosis 1 (NF1) mRNA","volume":"48","author":"Danglot G","year":"1994","unstructured":"Danglot G, Teinturier C, Duverger A, Bernheim A. Tissue-specific alternative splicing of neurofibromatosis 1 (NF1) mRNA. Biomed Pharmacother 1994;48(8-9):365-72","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"e_1_3_3_104_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(96)12730-0","article-title":"Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene","volume":"211","author":"Geist RT","year":"1996","unstructured":"Geist RT, Gutmann DH. Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci Lett 1996;211(2):85-8","journal-title":"Neurosci Lett"},{"issue":"7","key":"e_1_3_3_105_1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/hmg\/2.7.989","article-title":"An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle","volume":"2","author":"Gutman DH","year":"1993","unstructured":"Gutman DH, Andersen LB, Cole JL, et al. An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle. Hum Mol Genet 1993;2(7):989-92","journal-title":"Hum Mol Genet"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)63311-7"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/aja.1002020309"},{"issue":"3","key":"e_1_3_3_108_1","first-page":"315","article-title":"Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues","volume":"6","author":"Gutmann DH","year":"1995","unstructured":"Gutmann DH, Geist RT, Wright DE, Snider WD. Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues. Cell Growth Differ 1995;6(3):315-23","journal-title":"Cell Growth Differ"},{"issue":"5","key":"e_1_3_3_109_1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/1531-8249(199911)46:5<777::AID-ANA15>3.0.CO;2-H","article-title":"Developmental regulation of a neuron-specific neurofibromatosis 1 isoform","volume":"46","author":"Gutmann DH","year":"1999","unstructured":"Gutmann DH, Zhang Y, Hirbe A. Developmental regulation of a neuron-specific neurofibromatosis 1 isoform. Ann Neurol 1999;46(5):777-82","journal-title":"Ann Neurol"},{"issue":"2","key":"e_1_3_3_110_1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1006\/dbio.1994.1052","article-title":"Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development","volume":"161","author":"Huynh DP","year":"1994","unstructured":"Huynh DP, Nechiporuk T, Pulst SM. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev Biol 1994;161(2):538-51","journal-title":"Dev Biol"},{"issue":"2","key":"e_1_3_3_111_1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0378-1119(94)90695-5","article-title":"A novel isoform of the neurofibromatosis type-1 mRNA and a switch of isoforms during murine cell differentiation and proliferation","volume":"148","author":"Mantani A","year":"1994","unstructured":"Mantani A, Wakasugi S, Yokota Y, et al. A novel isoform of the neurofibromatosis type-1 mRNA and a switch of isoforms during murine cell differentiation and proliferation. Gene 1994;148(2):245-51","journal-title":"Gene"},{"issue":"3","key":"e_1_3_3_112_1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0006-291X(91)92029-J","article-title":"Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain","volume":"181","author":"Suzuki Y","year":"1991","unstructured":"Suzuki Y, Suzuki H, Kayama T, et al. Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. Biochem Biophys Res Commun 1991;181(3):955-61","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"e_1_3_3_113_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/excr.1996.0297","article-title":"NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors","volume":"228","author":"Metheny LJ","year":"1996","unstructured":"Metheny LJ, Skuse GR. NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors. Exp Cell Res 1996;228(1):44-9","journal-title":"Exp Cell Res"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0283-10.2010"},{"issue":"2","key":"e_1_3_3_115_1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2011.09.005","article-title":"PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice","volume":"232","author":"Brown JA","year":"2011","unstructured":"Brown JA, Xu J, Diggs-Andrews KA, et al. PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. Exp Neurol 2011;232(2):333-8","journal-title":"Exp Neurol"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-19-33"},{"issue":"5","key":"e_1_3_3_117_1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1083\/jcb.200608121","article-title":"Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena\/VASP pathway","volume":"177","author":"Lin YL","year":"2007","unstructured":"Lin YL, Lei YT, Hong CJ, Hsueh YP. Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena\/VASP pathway. J Cell Biol 2007;177(5):829-41","journal-title":"J Cell Biol"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05238.x"},{"issue":"25","key":"e_1_3_3_119_1","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1523\/JNEUROSCI.0933-07.2007","article-title":"Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation","volume":"27","author":"Ho IS","year":"2007","unstructured":"Ho IS, Hannan F, Guo HF, et al. Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation. J Neurosci 2007;27(25):6852-7","journal-title":"J Neurosci"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2005.09.043"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-131"},{"issue":"3","key":"e_1_3_3_122_1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial","volume":"300","author":"Krab LC","year":"2008","unstructured":"Krab LC, de Goede-Bolder A, Aarsen FK, et al. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 2008;300(3):287-94","journal-title":"JAMA"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70227-8"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2012.08.013"},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23793"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24093"},{"issue":"1","key":"e_1_3_3_127_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2012.03.009","article-title":"Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1","volume":"515","author":"Chabernaud C","year":"2012","unstructured":"Chabernaud C, Mennes M, Kardel PG, et al. Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1. Neurosci Lett 2012;515(1):28-33","journal-title":"Neurosci Lett"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2576"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30294"},{"key":"e_1_3_3_130_1","unstructured":"Neurofibromatosis Type 1 patient registry. Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT01410006&Search=Search"},{"key":"e_1_3_3_131_1","unstructured":"Modifying genes in neurofibromatosis 1. Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT01650142&Search=Search"},{"key":"e_1_3_3_132_1","unstructured":"Quality of friendships in children with neurofibromatosis. Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT00508235&Search=Search"},{"key":"e_1_3_3_133_1","unstructured":"How neurofibromatosis Type 1 (NF1) affects schoolwork and self-esteem. Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT01626846&Search=Search"},{"key":"e_1_3_3_134_1","unstructured":"Adaptation and quality of life among adults with neurofibromatosis type I. Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT00684398&Search=Search"},{"key":"e_1_3_3_135_1","unstructured":"Neuropsychological impairment and quality of life in neurofibromatosis type 1. Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT01851135&Search=Search"},{"key":"e_1_3_3_136_1","unstructured":"Neurobiology and treatment of reading disability in NF-1. Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT00624234&Search=Search"},{"key":"e_1_3_3_137_1","unstructured":"NF1-Attention: study of children with neurofibromatosis type 1 treated by methylphenidate. Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT00169611&Search=Search"},{"key":"e_1_3_3_138_1","unstructured":"Trial to evaluate the safety of lovastatin in individuals with neurofibromatosis type I (NF1). Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT00352599&Search=Search"},{"key":"e_1_3_3_139_1","unstructured":"A randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Available from: www.clinicaltrials.gov\/ct2\/results?term=NCT00853580&Search=Search"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737175.2014.953931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:33:56Z","timestamp":1770392036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737175.2014.953931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":138,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1586\/14737175.2014.953931"],"URL":"https:\/\/doi.org\/10.1586\/14737175.2014.953931","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}